Cargando…
Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil
BACKGROUND: Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because clinical forms vary and there are no gold standard methods to guide clinicians. The serolo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322275/ https://www.ncbi.nlm.nih.gov/pubmed/30616580 http://dx.doi.org/10.1186/s12879-018-3653-0 |
_version_ | 1783385588074807296 |
---|---|
author | Leturiondo, André Luiz Noronha, Ariani Batista do Nascimento, Monik Oney Oliveira Ferreira, Cynthia de Oliveira Rodrigues, Fabíola da Costa Moraes, Milton Ozório Talhari, Carolina |
author_facet | Leturiondo, André Luiz Noronha, Ariani Batista do Nascimento, Monik Oney Oliveira Ferreira, Cynthia de Oliveira Rodrigues, Fabíola da Costa Moraes, Milton Ozório Talhari, Carolina |
author_sort | Leturiondo, André Luiz |
collection | PubMed |
description | BACKGROUND: Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because clinical forms vary and there are no gold standard methods to guide clinicians. The serological rapid tests aid the clinical diagnosis and are available for field use. They are easy to perform, do not require special equipment or refrigeration and are cheaper than the molecular tests. METHODS: We evaluated the performance of two rapid serological tests (PGL1 and NDO-LID) in the discrimination of leprosy cases from healthy individuals at the Alfredo da Matta Foundation, a reference center for the disease in Manaus, Amazonas, Brazil. PGL1 and NDO-LID rapid tests are capable of detecting specific antibodies of M. leprae, IgM and IgM/IgG, respectively. A total of 530 healthy subjects and 171 patients (50 with paucibacillary and 121 multibacillary leprosy) were included in the study. RESULTS: Among the paucibacillary leprosy patients, the sensitivity was 34.0 and 32.0% for the NDO-LID and PGL1, respectively. In multibacillary leprosy patients, the NDO-LID sensitivity was 73.6% and the PGL1 was 81.0%. Serological tests demonstrated specificities of 75.9% for PGL-1 and 81.7% for NDO-LID. The positive predictive value (PPV), negative predictive value (NPV) and accuracy in multibacillary patients were 47.9, 93.1, and 80.2% respectively for the NDO-LID, and 43.4, 94.6 76.8% for PGL1. CONCLUSIONS: The tests showed limited capacity in the diagnosis of the disease, however, the high negative predictive value of the tests indicates a greater chance of true negatives in this group favoring exclusion of leprosy. This characteristic of the ML flow test is important in aiding clinical Diagnosis, especially in a region endemic to the disease and with other confounding skin conditions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3653-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6322275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63222752019-01-09 Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil Leturiondo, André Luiz Noronha, Ariani Batista do Nascimento, Monik Oney Oliveira Ferreira, Cynthia de Oliveira Rodrigues, Fabíola da Costa Moraes, Milton Ozório Talhari, Carolina BMC Infect Dis Research Article BACKGROUND: Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because clinical forms vary and there are no gold standard methods to guide clinicians. The serological rapid tests aid the clinical diagnosis and are available for field use. They are easy to perform, do not require special equipment or refrigeration and are cheaper than the molecular tests. METHODS: We evaluated the performance of two rapid serological tests (PGL1 and NDO-LID) in the discrimination of leprosy cases from healthy individuals at the Alfredo da Matta Foundation, a reference center for the disease in Manaus, Amazonas, Brazil. PGL1 and NDO-LID rapid tests are capable of detecting specific antibodies of M. leprae, IgM and IgM/IgG, respectively. A total of 530 healthy subjects and 171 patients (50 with paucibacillary and 121 multibacillary leprosy) were included in the study. RESULTS: Among the paucibacillary leprosy patients, the sensitivity was 34.0 and 32.0% for the NDO-LID and PGL1, respectively. In multibacillary leprosy patients, the NDO-LID sensitivity was 73.6% and the PGL1 was 81.0%. Serological tests demonstrated specificities of 75.9% for PGL-1 and 81.7% for NDO-LID. The positive predictive value (PPV), negative predictive value (NPV) and accuracy in multibacillary patients were 47.9, 93.1, and 80.2% respectively for the NDO-LID, and 43.4, 94.6 76.8% for PGL1. CONCLUSIONS: The tests showed limited capacity in the diagnosis of the disease, however, the high negative predictive value of the tests indicates a greater chance of true negatives in this group favoring exclusion of leprosy. This characteristic of the ML flow test is important in aiding clinical Diagnosis, especially in a region endemic to the disease and with other confounding skin conditions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3653-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-07 /pmc/articles/PMC6322275/ /pubmed/30616580 http://dx.doi.org/10.1186/s12879-018-3653-0 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Leturiondo, André Luiz Noronha, Ariani Batista do Nascimento, Monik Oney Oliveira Ferreira, Cynthia de Oliveira Rodrigues, Fabíola da Costa Moraes, Milton Ozório Talhari, Carolina Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil |
title | Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil |
title_full | Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil |
title_fullStr | Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil |
title_full_unstemmed | Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil |
title_short | Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil |
title_sort | performance of serological tests pgl1 and ndo-lid in the diagnosis of leprosy in a reference center in brazil |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322275/ https://www.ncbi.nlm.nih.gov/pubmed/30616580 http://dx.doi.org/10.1186/s12879-018-3653-0 |
work_keys_str_mv | AT leturiondoandreluiz performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil AT noronhaarianibatista performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil AT donascimentomonikoneyoliveira performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil AT ferreiracynthiadeoliveira performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil AT rodriguesfabioladacosta performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil AT moraesmiltonozorio performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil AT talharicarolina performanceofserologicaltestspgl1andndolidinthediagnosisofleprosyinareferencecenterinbrazil |